期刊文献+

TNFSF14及其受体LTβR和HVEM在病毒肝炎中的作用 被引量:3

Role of TNFSF14 and its receptors LTβR and HVEM in pathogenesis of virus hepatitis
下载PDF
导出
摘要 目的:探讨TNFSF14(即LIGHT)及其受体LTβR和HVEM在暴发性病毒肝炎中的作用。方法:MHV-3感染易感小鼠建立暴发性病毒肝炎模型,通过HE染色和血清ALT水平的测定比较了LIGHT KO和WT两组小鼠的肝损情况;定量PCR技术检测了MHV-3感染C57BL/6小鼠后各时相点(0 h、12 h、24 h、48 h、72 h)肝脏和脾脏组织HVEM和LTβR的mRNA水平。流式细胞术检测了临床病毒性重症肝炎病人PBMC中HVEM和LTβR的表达情况。结果:MHV-3感染72 h后,WT小鼠的肝脏出现明显坏死灶,而LIGHT KO小鼠的肝脏则未见异常;LIGHT KO小鼠血清中的ALT浓度也显著低于WT组(P<0.01)。MHV-3感染48 h后,C57BL/6小鼠脾脏中HVEM及LTβR的mRNA水平均有显著升高(P<0.05);肝脏中LTβR表达在12 h时就有显著上调(P<0.01)。与之一致的是,临床重症肝炎病人PBMC中HVEM和LTβR的表达较正常人均有明显升高。结论:TNFSF14可能通过与其受体LTβR和HVEM的相互作用在病毒诱发的暴发性肝炎中扮演重要角色。 Objective: To explore the role of TNFSF14 and its receptors LTβR and HVEM in the pathogenesis of virus hepatitis. Methods: Marine fulminant viral hepatitis model was established by infecting mice with MHV-3. Liver tissue destruction in LIGHT KO and WT mice were analyzed by HE staining and ALT levels in serum by automatic biochemical analyzer. The mRNA levels of HVEM and LTβR in the liver and spleen tissues in the indicated time points( 0 h,12 h,24 h,48 h,72 h) were detected by quantitative-PCR. The expression of HVEM and LTβR on PBMC in patients with severe hepatitis were measured by flow cytometry. Results: In the MHV-3-induced murine fulminant hepatitis model,liver injury in LIGHT KO mice was obviously decreased than that of WT mice,and ALT levels was also significantly lower than that of WT mice( P〈 0. 01). The mRNA of HVEM and LTβR in the spleen were increased significantly after 48 h postinfection with MHV-3( P〈 0. 05); The level of LTβR mRNA in liver was significantly up-regulated in 12 h postinfection with MHV-3( P〈 0. 01). Compared to healthy volunteers,the expression of both HVEM and LTβR on PBMC in patients with severe hepatitis was remarkably enhanced. Conclusion: TNFSF14 and its receptors LTβR and HVEM play a critical role in the pathogenesis of viral fulminant hepatitis.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第12期1591-1594,共4页 Chinese Journal of Immunology
基金 国家自然科学基金面上项目(31270929) 重庆市自然科学基金面上项目(cstc2013jcyj A10129)资助
关键词 TNFSF14 LTβR HVEM 病毒性肝炎 TNFSF14 LTβR HVEM Viral hepatitis
  • 相关文献

参考文献17

  • 1Lu Y,Wang X,Wang H,et al. Liver TCR* CD3+ CIM- CDS-T cells contribute to murine hepatitis virus strain 3-induced hepatic injury through a TNF-dependent pathway [ J ]. Mol Immunol, 2012,52(5-4) :229-236.
  • 2Massari S, Ciccarese S, Antonacci R, et al. Structural and comparative analysis of the T cell receptor gamma TRGlocus in Oryctolagus cuniculus [ J ]. Immunogenetics, 2012, 64 ( 10 ) : 773-779.
  • 3Yokomori K, Stohlman SA, Lai MM. The detection and characterizeation of multiple hemagglutinin ester~e(HE) defective viruses in the mouse brain during subacute demyelination induced by mouse hepatitis virus [ J ]. Virology, 1993,192 : 170-178.
  • 4Granger SW, Butrovieh KD, Houshmand P, et al. Genomic characterization of LIGHT roveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by ahemate splicing or proteolysis [ J]. J Immunol ,2001,167 ( 11 ) : 5122-5128.
  • 5曹朝晖,董世访,江伟凡,尹卫东,许桂莲.自身免疫疾病中的LIGHT-LTβR/HVEM信号通路的研究进展[J].细胞与分子免疫学杂志,2011,27(12):1382-1384. 被引量:6
  • 6Zhai Y, Guo R, Hsu TL, et al. LIGHT, a novel ligand for lymphptoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer [ J ]. Clin Invest, 1998,102 : 1142-1151.
  • 7Byrue JA,Oldstone MB. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic chofiomeningitis virus: Clearance of virus in vivo [J]. J Virol,1984,51 (3) :682-686.
  • 8Tamada K, Shimozaki K, Chapoval AI, et al. Modulation of T- cell- mediated immunity in tumor and graft- versus- host Disease models through the LIGHT co- stimulatory pathway [ J]. Nat Med,2000,6 (3) :283-289.
  • 9Ye Q, Fraser CC, Gao W, et aL Modulation of LIGHT- HVEM cos- timulation prolongs cardiac allograft survival [ J ]. J Exp Med, 2002,195 ( 6 ) :795-800.
  • 10Wang J,Anders RA, Wang Y,et al. The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease[J].J Immuno1,2005,174 ( 12 ) : 8173-8182.

二级参考文献60

  • 1张光波,陈永井,姜智,於葛华,杨明峰,施勤,王勤,李文香,张学光.人B7-H3基因转染及其生物学功能的研究[J].现代免疫学,2004,24(6):455-459. 被引量:9
  • 2Granger SW, Butrovich KD, Houshmand P, et al. Genomic characterization of LIGHT reveals linkage to an immune response locus on chro- mosome 19p13. 3 and distinct isoforms generated by alternate splicing or proteolysis[ J]. J Immunol, 2001, 167(11) : 5122 -5128.
  • 3Vincenti F. Costimulation blockade in autoimmunity and transplantation[J]. J Allergy Clin Immunol, 2008, 121(2) : 299 -306.
  • 4Kroczek R, Hamelmann E. T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies[ J ]. J Allergy CIin Immunol, 2005, 116 (4) : 9006 -9009.
  • 5Bodmer JL, Sehneider P, Tschopp J. The molecular architecture of the TNF superfamily[ J]. Trends Biochem Sei, 2002, 27( 1 ) : 19 -26.
  • 6Tamada K, Shimozaki K, Chapoval AI, et al. LIGHT, a TNF like molecule, eostimulates T cell proliferation and is required for dendritic eell-medlated altogeneie T cell response [ J ]. J Immunol, 2000, 164 (8) : 4105 -4110.
  • 7Del Rio ML, Lucas CL, Buhler L, et al. HVEM/LIGHT/BTLA/ CD160 cosigualing pathways as targets for immune regulation[J]. J Leukoc Biol, 2010, 87(2) : 223 -225.
  • 8Rooney IA, Butrovich KD, Glass AA, et al. The lymphotoxin-beta re- ceptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells[ J]. J Bid Chem, 2000, 275(19) : 14307 - 14315.
  • 9Tarnada K, Shimozaki K, Chapoval AI, et al. Modulation of T-cell- mediated immunity in tumor and graft-versus-host disease models through the LIGHT costimulatory pathway [ J]. Nat Med, 2000, 6 (3) : 283 -289.
  • 10Granger SW, Rickert S. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity[ J]. Cytokine Growth Factor Rev, 2003, 14 (34) : 289 - 296.

共引文献14

同被引文献10

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部